Litigation Details for AbbVie Inc. v. Payer Matrix, LLC (N.D. Ill. 2023)
✉ Email this page to a colleague
AbbVie Inc. v. Payer Matrix, LLC (N.D. Ill. 2023)
Docket | ⤷ Try a Trial | Date Filed | 2023-05-05 |
Court | District Court, N.D. Illinois | Date Terminated | |
Cause | 28:1332 Diversity-Fraud | Assigned To | Jorge Luis Alonso |
Jury Demand | Plaintiff | Referred To | Young B. Kim |
Patents | 7,514,444; 8,926,975; 9,125,889; 9,655,857; 9,801,881 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AbbVie Inc. v. Payer Matrix, LLC
Biologic Drugs cited in AbbVie Inc. v. Payer Matrix, LLC
Details for AbbVie Inc. v. Payer Matrix, LLC (N.D. Ill. 2023)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2023-11-29 | 148 | declaration | U.S. Patent No. 7,514,444 (filed Dec. 3, 2006). 135 U.S. Patent No. 9,801,…set of patents or individual patents. We have a large portfolio of formulation patents that have… dosing patents. We have a large portfolio of dosing patents. We have dosing patents beyond…earlier patents but with more specificity. Because the U.S. patent system grants a 20-year patent term to… to all approved patents no matter what the patent covers, the successive patents effectively reset the | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |